Numerous materials, both autologous and nonautologous, have been used for augmentation of soft-tissue defects in the facial region. Each has its limitations. There is no ideal material for soft-tissue augmentation. Alloderm dermal graft (LifeCell Corporation, Woodlands, TX) combines the benefits of autografts and allografts. The authors report its use in 11 patients who have soft-tissue defects or scarring on the face. No serious complications such as rejection, mobilization, absorption, dislocation, or extrusion were encountered. The use of Alloderm in these patients minimized two problems: donor site morbidity and lack of adequate tissue for reconstruction. Alloderm is shown to be an excellent augmentation material for soft-tissue defects. The absence of a donor site defect, and adequate tissue for reconstruction are particularly helpful in the pediatric population.